|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Deferred offering costs associated with initial public offering | ||||||||
| Investments held in Trust Account | ||||||||
| Total Assets | ||||||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | ||||||||
| Due to related parties | ||||||||
| Accrued expenses | ||||||||
| Note payable - related party | ||||||||
| Advance from Sponsor for private placement warrants associated with the initial public offering | ||||||||
| Total current liabilities | ||||||||
| Deferred underwriting commissions | ||||||||
| Derivative warrant liabilities | ||||||||
| Total liabilities | ||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 57,500,000 shares issued and outstanding at $10.016 and $10.000 per share redemption value as of June 30, 2022 and December 31, 2021, respectively | ||||||||
| Shareholders' Deficit: | ||||||||
| Preference shares, $0.0001 par value 1,000,000 shares authorized no shares issued or outstanding | ||||||||
| Common Stock, Value, Issued | ||||||||
| Class A ordinary shares | ||||||||
| Class B ordinary shares | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total shareholders' deficit | ||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit |
Loading...
